The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In-Vitro Toxicology & Toxicity Testing-Global Market Insights and Sales Trends 2025
Synopsis
The global In-Vitro Toxicology & Toxicity Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of In-Vitro Toxicology & Toxicity Testing in various end use industries. The expanding demands from the Pharmaceutical Industry, Chemical Industry, Food Industry and Other, are propelling In-Vitro Toxicology & Toxicity Testing market. Cell Culture Technology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the High Throughput Technologies segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for In-Vitro Toxicology & Toxicity Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the In-Vitro Toxicology & Toxicity Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In-Vitro Toxicology & Toxicity Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In-Vitro Toxicology & Toxicity Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In-Vitro Toxicology & Toxicity Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In-Vitro Toxicology & Toxicity Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In-Vitro Toxicology & Toxicity Testing covered in this report include Agilent Technologies, Abbott, Bio-Rad Laboratories, Bioreliance, Catalent, Charles River Laboratories International, Covance, Cyprotex and Eurofins Scientific, etc.
The global In-Vitro Toxicology & Toxicity Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Abbott
Bio-Rad Laboratories
Bioreliance
Catalent
Charles River Laboratories International
Covance
Cyprotex
Eurofins Scientific
GE Healthcare
Life Technologies Corporation
Quest Diagnostics
Global In-Vitro Toxicology & Toxicity Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In-Vitro Toxicology & Toxicity Testing market, Segment by Type:
Cell Culture Technology
High Throughput Technologies
Molecular Imaging Technologies
Omics Technologies
Global In-Vitro Toxicology & Toxicity Testing market, by Application
Pharmaceutical Industry
Chemical Industry
Food Industry
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In-Vitro Toxicology & Toxicity Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global In-Vitro Toxicology & Toxicity Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of In-Vitro Toxicology & Toxicity Testing in various end use industries. The expanding demands from the Pharmaceutical Industry, Chemical Industry, Food Industry and Other, are propelling In-Vitro Toxicology & Toxicity Testing market. Cell Culture Technology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the High Throughput Technologies segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for In-Vitro Toxicology & Toxicity Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the In-Vitro Toxicology & Toxicity Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In-Vitro Toxicology & Toxicity Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In-Vitro Toxicology & Toxicity Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In-Vitro Toxicology & Toxicity Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In-Vitro Toxicology & Toxicity Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In-Vitro Toxicology & Toxicity Testing covered in this report include Agilent Technologies, Abbott, Bio-Rad Laboratories, Bioreliance, Catalent, Charles River Laboratories International, Covance, Cyprotex and Eurofins Scientific, etc.
The global In-Vitro Toxicology & Toxicity Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technologies
Abbott
Bio-Rad Laboratories
Bioreliance
Catalent
Charles River Laboratories International
Covance
Cyprotex
Eurofins Scientific
GE Healthcare
Life Technologies Corporation
Quest Diagnostics
Global In-Vitro Toxicology & Toxicity Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In-Vitro Toxicology & Toxicity Testing market, Segment by Type:
Cell Culture Technology
High Throughput Technologies
Molecular Imaging Technologies
Omics Technologies
Global In-Vitro Toxicology & Toxicity Testing market, by Application
Pharmaceutical Industry
Chemical Industry
Food Industry
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In-Vitro Toxicology & Toxicity Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In-Vitro Toxicology & Toxicity Testing
1.1 In-Vitro Toxicology & Toxicity Testing Market Overview
1.1.1 In-Vitro Toxicology & Toxicity Testing Product Scope
1.1.2 In-Vitro Toxicology & Toxicity Testing Market Status and Outlook
1.2 Global In-Vitro Toxicology & Toxicity Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In-Vitro Toxicology & Toxicity Testing Market Size by Region (2018-2029)
1.4 Global In-Vitro Toxicology & Toxicity Testing Historic Market Size by Region (2018-2023)
1.5 Global In-Vitro Toxicology & Toxicity Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In-Vitro Toxicology & Toxicity Testing Market Size (2018-2029)
1.6.1 North America In-Vitro Toxicology & Toxicity Testing Market Size (2018-2029)
1.6.2 Europe In-Vitro Toxicology & Toxicity Testing Market Size (2018-2029)
1.6.3 Asia-Pacific In-Vitro Toxicology & Toxicity Testing Market Size (2018-2029)
1.6.4 Latin America In-Vitro Toxicology & Toxicity Testing Market Size (2018-2029)
1.6.5 Middle East & Africa In-Vitro Toxicology & Toxicity Testing Market Size (2018-2029)
2 In-Vitro Toxicology & Toxicity Testing Market by Type
2.1 Introduction
2.1.1 Cell Culture Technology
2.1.2 High Throughput Technologies
2.1.3 Molecular Imaging Technologies
2.1.4 Omics Technologies
2.2 Global In-Vitro Toxicology & Toxicity Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In-Vitro Toxicology & Toxicity Testing Historic Market Size by Type (2018-2023)
2.2.2 Global In-Vitro Toxicology & Toxicity Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Type (2018-2029)
3 In-Vitro Toxicology & Toxicity Testing Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Industry
3.1.2 Chemical Industry
3.1.3 Food Industry
3.1.4 Other
3.2 Global In-Vitro Toxicology & Toxicity Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In-Vitro Toxicology & Toxicity Testing Historic Market Size by Application (2018-2023)
3.2.2 Global In-Vitro Toxicology & Toxicity Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In-Vitro Toxicology & Toxicity Testing Revenue Breakdown by Application (2018-2029)
4 In-Vitro Toxicology & Toxicity Testing Competition Analysis by Players
4.1 Global In-Vitro Toxicology & Toxicity Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In-Vitro Toxicology & Toxicity Testing as of 2022)
4.3 Date of Key Players Enter into In-Vitro Toxicology & Toxicity Testing Market
4.4 Global Top Players In-Vitro Toxicology & Toxicity Testing Headquarters and Area Served
4.5 Key Players In-Vitro Toxicology & Toxicity Testing Product Solution and Service
4.6 Competitive Status
4.6.1 In-Vitro Toxicology & Toxicity Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technologies
5.1.1 Agilent Technologies Profile
5.1.2 Agilent Technologies Main Business
5.1.3 Agilent Technologies In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.1.4 Agilent Technologies In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technologies Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.2.4 Abbott In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.3.4 Bio-Rad Laboratories In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Bioreliance Recent Developments
5.4 Bioreliance
5.4.1 Bioreliance Profile
5.4.2 Bioreliance Main Business
5.4.3 Bioreliance In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.4.4 Bioreliance In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Bioreliance Recent Developments
5.5 Catalent
5.5.1 Catalent Profile
5.5.2 Catalent Main Business
5.5.3 Catalent In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.5.4 Catalent In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Catalent Recent Developments
5.6 Charles River Laboratories International
5.6.1 Charles River Laboratories International Profile
5.6.2 Charles River Laboratories International Main Business
5.6.3 Charles River Laboratories International In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.6.4 Charles River Laboratories International In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Charles River Laboratories International Recent Developments
5.7 Covance
5.7.1 Covance Profile
5.7.2 Covance Main Business
5.7.3 Covance In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.7.4 Covance In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Covance Recent Developments
5.8 Cyprotex
5.8.1 Cyprotex Profile
5.8.2 Cyprotex Main Business
5.8.3 Cyprotex In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.8.4 Cyprotex In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Cyprotex Recent Developments
5.9 Eurofins Scientific
5.9.1 Eurofins Scientific Profile
5.9.2 Eurofins Scientific Main Business
5.9.3 Eurofins Scientific In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.9.4 Eurofins Scientific In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Eurofins Scientific Recent Developments
5.10 GE Healthcare
5.10.1 GE Healthcare Profile
5.10.2 GE Healthcare Main Business
5.10.3 GE Healthcare In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.10.4 GE Healthcare In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.10.5 GE Healthcare Recent Developments
5.11 Life Technologies Corporation
5.11.1 Life Technologies Corporation Profile
5.11.2 Life Technologies Corporation Main Business
5.11.3 Life Technologies Corporation In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.11.4 Life Technologies Corporation In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Life Technologies Corporation Recent Developments
5.12 Quest Diagnostics
5.12.1 Quest Diagnostics Profile
5.12.2 Quest Diagnostics Main Business
5.12.3 Quest Diagnostics In-Vitro Toxicology & Toxicity Testing Products, Services and Solutions
5.12.4 Quest Diagnostics In-Vitro Toxicology & Toxicity Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Quest Diagnostics Recent Developments
6 North America
6.1 North America In-Vitro Toxicology & Toxicity Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In-Vitro Toxicology & Toxicity Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Toxicology & Toxicity Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In-Vitro Toxicology & Toxicity Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Toxicology & Toxicity Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In-Vitro Toxicology & Toxicity Testing Market Dynamics
11.1 In-Vitro Toxicology & Toxicity Testing Industry Trends
11.2 In-Vitro Toxicology & Toxicity Testing Market Drivers
11.3 In-Vitro Toxicology & Toxicity Testing Market Challenges
11.4 In-Vitro Toxicology & Toxicity Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
